UHS — Universal Health Services stock price and chart

UHS

Universal Health ServicesStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.01% · Russell 1000 0.01% · Russell 3000 0.01% · US Stock Market 0.01% · MSCI World 0.009% · MSCI ACWI 0.008%

$176.69-2.25%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

80.0100.0120.0140.0160.0180.0200.0220.0240.0010.0M20.0M$176.69

2026-09-18

Price$176.69

MA20$164.98

MA50$188.20

Vol4.5M

What would $1,000 invested in UHS be worth today? →

UHS returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $176.69
Change YTD: -18.96%
Next earnings: Oct 26, 2026
Market cap: 10.4B2016-09 12.1B2026-09 10.4B-14.0% over the window
Enterprise value: 15.7B
Shares outstanding: 58.9M2016-06 98.4M2026-06 58.9M-40.1% over the window
52W low: $140.08
52W high: $246.33
From 52W high: -28.27%
From 52W low: +26.14%
52W range: 34%
Beta: 1.06

Volume

Rel volume: 2.56×
30D volume: 695.2K
30D $ vol: 120.8M

Fundamentals

Sales (ttm): 18.1B2016-06 9.4B2026-06 18.1B+92.2% over the window
Sales/share: $307.362016-06 $95.782026-06 $307.36+220.9% over the window
EPS (ttm): $24.572016-06 $7.042026-06 $24.57+249.1% over the window
FCF (ttm): 845.4M2016-06 916.6M2026-06 845.4M-7.8% over the window
FCF/share: $14.342016-06 $9.322026-06 $14.34+54.0% over the window
Book value/share: $127.492016-06 $43.732026-06 $127.49+191.5% over the window
Net margin: 8.42%2016-06 7.4%2026-06 8.4%+13.4% over the window
ROE: 20.31%2016-06 16.3%2026-06 20.3%+24.8% over the window
ROA: 9.58%2016-06 7.3%2026-06 9.6%+30.5% over the window
Debt / equity: 0.54×2016-06 0.812026-06 0.54-33.2% over the window
Current ratio: 1.122016-06 1.272026-06 1.12-11.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +10.06%2025-06-30 → 2026-06-3016.5B → 18.1B (+10.0% total)+9.49%2023-06-30 → 2026-06-3013.8B → 18.1B (+31.3% total)+8.21%2021-06-30 → 2026-06-3012.2B → 18.1B (+48.4% total)+6.75%2016-06-30 → 2026-06-309.4B → 18.1B (+92.2% total)
Net income: +21.03%2025-06-30 → 2026-06-301.3B → 1.5B (+21.0% total)+30.15%2023-06-30 → 2026-06-30692.1M → 1.5B (+120.5% total)+7.08%2021-06-30 → 2026-06-301.1B → 1.5B (+40.8% total)+8.10%2016-06-30 → 2026-06-30700.4M → 1.5B (+117.9% total)
FCF: -6.23%2025-06-30 → 2026-06-30901.5M → 845.4M (-6.2% total)+18.42%2023-06-30 → 2026-06-30509M → 845.4M (+66.1% total)+37.94%2021-06-30 → 2026-06-30169.3M → 845.4M (+399.2% total)-0.81%2016-06-30 → 2026-06-30916.6M → 845.4M (-7.8% total)
Shares: -7.39%2025-06-30 → 2026-06-3063.6M → 58.9M (-7.4% total)-5.30%2023-06-30 → 2026-06-3069.4M → 58.9M (-15.1% total)-6.65%2021-06-30 → 2026-06-3083.1M → 58.9M (-29.1% total)-5.00%2016-06-30 → 2026-06-3098.4M → 58.9M (-40.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +29.72%2025-06-30 → 2026-06-30$18.95 → $24.57 (+29.7% total)+36.60%2023-06-30 → 2026-06-30$9.64 → $24.57 (+154.9% total)+14.22%2021-06-30 → 2026-06-30$12.64 → $24.57 (+94.4% total)+13.32%2016-06-30 → 2026-06-30$7.04 → $24.57 (+249.1% total)
Sales/share: +18.84%2025-06-30 → 2026-06-30$258.65 → $307.36 (+18.8% total)+15.62%2023-06-30 → 2026-06-30$198.85 → $307.36 (+54.6% total)+15.92%2021-06-30 → 2026-06-30$146.88 → $307.36 (+109.3% total)+12.37%2016-06-30 → 2026-06-30$95.78 → $307.36 (+220.9% total)
FCF/share: +1.26%2025-06-30 → 2026-06-30$14.17 → $14.34 (+1.3% total)+25.05%2023-06-30 → 2026-06-30$7.33 → $14.34 (+95.6% total)+47.76%2021-06-30 → 2026-06-30$2.04 → $14.34 (+604.2% total)+4.41%2016-06-30 → 2026-06-30$9.32 → $14.34 (+54.0% total)
Book value/share: +15.42%2025-06-30 → 2026-06-30$110.47 → $127.49 (+15.4% total)+13.27%2023-06-30 → 2026-06-30$87.72 → $127.49 (+45.3% total)+10.34%2021-06-30 → 2026-06-30$77.95 → $127.49 (+63.6% total)+11.29%2016-06-30 → 2026-06-30$43.73 → $127.49 (+191.5% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$0.80 → $0.80 (+0.0% total)+0.00%2023-06-30 → 2026-06-30$0.80 → $0.80 (+0.0% total)+15.13%2021-06-30 → 2026-06-30$0.40 → $0.80 (+102.3% total)+7.35%2016-06-30 → 2026-06-30$0.39 → $0.80 (+103.2% total)
Price: -6.07%2025-09-18 → 2026-09-18$188.11 → $176.69 (-6.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.51%2023-09-18 → 2026-09-18$127.43 → $176.69 (+38.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.90%2021-09-17 → 2026-09-18$145.92 → $176.69 (+21.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.64%2016-09-16 → 2026-09-18$123.51 → $176.69 (+43.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -5.67%2025-09-18 → 2026-09-18$187.29 → $176.69 (-5.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.00%2023-09-18 → 2026-09-18$125.75 → $176.69 (+40.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.44%2021-09-17 → 2026-09-18$142.20 → $176.69 (+24.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.09%2016-09-16 → 2026-09-18$118.27 → $176.69 (+49.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 7.2×2016-09 17.262026-09 6.82-60.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 5.1×2016-09 9.402026-09 5.06-46.2% over the window
Fwd P/E: 7.6×
P/S (ttm)Market cap ÷ TTM revenue.: 0.6×2016-09 1.262026-09 0.57-54.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.4×2016-09 2.762026-09 1.39-49.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 12.3×2016-09 13.432026-09 12.32-8.3% over the window
EV/EBITDA (fy): 5.8×
EV/Sales (ttm): 0.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.12%2016-06 7.6%2026-06 9.7%+28.0% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.45%
Dividend/share (fwd): $0.80
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 58.9M ÷ 63.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 7.39%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (7.39%) + dividends paid over that year ($49.6M) ÷ market_cap_at(2025-06-30) ($11.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 7.82%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.1B) ÷ today's market cap ($10.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 10.15%2016-06 3.1%2026-06 12.1%+294.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.1B + TTM dividends $49.6M) ÷ today's market cap ($10.4B). Same caveat as the cash buyback yield.: 10.62%2016-06 3.4%2026-06 12.7%+273.3% over the window

Vs own 10Y history

P/E: 4th
P/OI: 4th
P/S: 5th
P/B: 8th
P/FCF: 25th

Bar = where today’s multiple sits in UHS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-2.25%

+1.06%

+2.08%

+25.16%

YTD

-18.96%

-6.07%

+21.09%

Financial statements

Open full UHS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Universal Health Services (UHS) trades at $176.69 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes UHS’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full UHS financial statements →

UHS — Universal Health Services price, chart and key statistics